Literature DB >> 26104445

vls Antigenic Variation Systems of Lyme Disease Borrelia: Eluding Host Immunity through both Random, Segmental Gene Conversion and Framework Heterogeneity.

Steven J Norris1.   

Abstract

Spirochetes that cause Lyme borreliosis (also called Lyme disease) possess the vls locus, encoding an elaborate antigenic variation system. This locus contains the expression site vlsE as well as a contiguous array of vls silent cassettes, which contain variations of the central cassette region of vlsE. The locus is present on one of the many linear plasmids in the organism, e.g. plasmid lp28-1 in the strain Borrelia burgdorferi B31. Changes in the sequence of vlsE occur continuously during mammalian infection and consist of random, segmental, unidirectional recombination events between the silent cassettes and the cassette region of vlsE. These gene conversion events do not occur during in vitro culture or the tick portion of the infection cycle of B. burgdorferi or the other related Borrelia species that cause Lyme disease. The mechanism of recombination is largely unknown, but requires the RuvAB Holliday junction branch migrase. Other features of the vls locus also appear to be required, including cis locations of vlsE and the silent cassettes and high G+C content and GC skew. The vls system is required for long-term survival of Lyme Borrelia in infected mammals and represents an important mechanism of immune evasion. In addition to sequence variation, immune selection also results in significant heterogeneity in the sequence of the surface lipoprotein VlsE. Despite antigenic variation, VlsE generates a robust antibody response, and both full-length VlsE and the C6 peptide (corresponding to invariant region 6) are widely used in immunodiagnostic tests for Lyme disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26104445      PMCID: PMC4480602          DOI: 10.1128/microbiolspec.MDNA3-0038-2014

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  81 in total

1.  Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids.

Authors:  Qiyuan Dai; Blanca I Restrepo; Stephen F Porcella; Sandra J Raffel; Tom G Schwan; Alan G Barbour
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

2.  Antibodies to whole-cell or recombinant antigens of Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti in white-footed mice.

Authors:  Louis A Magnarelli; Kirby C Stafford; Jacob W Ijdo; Erol Fikrig
Journal:  J Wildl Dis       Date:  2006-10       Impact factor: 1.535

3.  Borrelia afzelii gene expression in Ixodes ricinus (Acari: Ixodidae) ticks.

Authors:  Juraj Koci; Markéta Derdákova; Kamila Peterková; Mária Kazimirová; Diana Selyemová; Milan Labuda
Journal:  Vector Borne Zoonotic Dis       Date:  2006       Impact factor: 2.133

4.  Lack of detectable variation at Borrelia burgdorferi vlsE locus in ticks.

Authors:  Leanna K Nosbisch; Aravinda M de Silva
Journal:  J Med Entomol       Date:  2007-01       Impact factor: 2.278

5.  The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens.

Authors:  Troy Bankhead; George Chaconas
Journal:  Mol Microbiol       Date:  2007-08-21       Impact factor: 3.501

Review 6.  Lyme disease: European perspective.

Authors:  Gerold Stanek; Franc Strle
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

7.  Antigenicity and recombination of VlsE, the antigenic variation protein of Borrelia burgdorferi, in rabbits, a host putatively resistant to long-term infection with this spirochete.

Authors:  Monica E Embers; Fang Ting Liang; Jerrilyn K Howell; Mary B Jacobs; Jeanette E Purcell; Steven J Norris; Barbara J B Johnson; Mario T Philipp
Journal:  FEMS Immunol Med Microbiol       Date:  2007-06-26

8.  Borrelia burgdorferi vlsE antigenic variation is not mediated by RecA.

Authors:  Dionysios Liveris; Vishwaroop Mulay; Sabina Sandigursky; Ira Schwartz
Journal:  Infect Immun       Date:  2008-07-07       Impact factor: 3.441

9.  Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.

Authors:  A Marangoni; A Moroni; S Accardo; R Cevenini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-16       Impact factor: 3.267

Review 10.  Skin manifestations of lyme borreliosis: diagnosis and management.

Authors:  Robert R Müllegger; Martin Glatz
Journal:  Am J Clin Dermatol       Date:  2008       Impact factor: 7.403

View more
  46 in total

1.  Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.

Authors:  Claudia R Molins; Mark J Delorey; Adam Replogle; Christopher Sexton; Martin E Schriefer
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

2.  mRNA transcript distribution bias between Borrelia burgdorferi bacteria and their outer membrane vesicles.

Authors:  Anjali Malge; Vikas Ghai; Panga Jaipal Reddy; David Baxter; Taek-Kyun Kim; Robert L Moritz; Kai Wang
Journal:  FEMS Microbiol Lett       Date:  2018-07-01       Impact factor: 2.742

3.  Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Authors:  Diane G Edmondson; Sabitha Prabhakaran; Steven J Norris; Amy J Ullmann; Joe Piesman; Marc Dolan; Christian Probst; Christiane Radzimski; Winfried Stöcker; Lars Komorowski
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

4.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

5.  Molecular Mechanisms of hsdS Inversions in the cod Locus of Streptococcus pneumoniae.

Authors:  Jing-Wen Li; Jing Li; Juanjuan Wang; Chunhao Li; Jing-Ren Zhang
Journal:  J Bacteriol       Date:  2019-02-25       Impact factor: 3.490

6.  Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits.

Authors:  Artem S Rogovskyy; Salvador Eugenio C Caoili; Yurij Ionov; Helen Piontkivska; Pavel Skums; Viachaslau Tsyvina; Alex Zelikovsky; Suryakant D Waghela
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

7.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

8.  Plasticity in early immune evasion strategies of a bacterial pathogen.

Authors:  Quentin Bernard; Alexis A Smith; Xiuli Yang; Juraj Koci; Shelby D Foor; Sarah D Cramer; Xuran Zhuang; Jennifer E Dwyer; Yi-Pin Lin; Emmanuel F Mongodin; Adriana Marques; John M Leong; Juan Anguita; Utpal Pal
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

Review 9.  Changing of the guard: How the Lyme disease spirochete subverts the host immune response.

Authors:  George Chaconas; Mildred Castellanos; Theodore B Verhey
Journal:  J Biol Chem       Date:  2019-11-21       Impact factor: 5.157

Review 10.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.